Farms.com Home   News

South Korea Crop Delegation Visits MN

Standing in front of his corn crop, Courtland farmer Tim Waibel explained to a group of South Korean grain buyers on Friday the importance of moisture levels when deciding when it’s time for harvest.

“When you start harvesting corn that is 18% moisture, it is easy to get it over-dry,” he said. “And if it’s too wet, it takes too much money in gas and electricity to [dry] it.”

Waibel’s comments came at the end of a two-day tour the South Korean group took of agricultural sites around south-central Minnesota last week. The group also visited the CHS river terminal in Savage, the UFC shuttle terminal in Brownton, CHS headquarters, and the Minnesota Corn office.

The tour was organized by U.S. Grains & BioProducts Council (USGBC), with in-state support from Minnesota Corn. The goal was to increase confidence among South Korean buyers in U.S. corn, which the council says could lead them to purchase more American corn and corn coproducts.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.